These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 29877856)
1. PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing. Allen LV Int J Pharm Compd; 2018; 22(2):92. PubMed ID: 29877856 [No Abstract] [Full Text] [Related]
2. [Medicines raw materials used in compounding medicines: an update of the legislation]. Huyghebaert C; Leuckx S J Pharm Belg; 2010 Mar; (1):16-8. PubMed ID: 20429391 [No Abstract] [Full Text] [Related]
3. [Maintaining standards of good compounding (N.B.F.)]. Castoldi B; Fumagalli A; Mazzoldi G Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351 [No Abstract] [Full Text] [Related]
4. The Drug Quality and Security Act--mind the gaps. Outterson K N Engl J Med; 2014 Jan; 370(2):97-9. PubMed ID: 24369048 [No Abstract] [Full Text] [Related]
5. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories. Jimenez FA Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711 [No Abstract] [Full Text] [Related]
6. Pharmaceutical controls for drug availability. Bethel RF Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040 [No Abstract] [Full Text] [Related]
7. Proposed current good manufacturing practice and supplemental regulations. Korun FD Bull Parenter Drug Assoc; 1976; 30(3):139-42. PubMed ID: 1268432 [No Abstract] [Full Text] [Related]
8. Panel discussion: in process control and inspection for quality assurance. 3. Brofazi FR Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572 [No Abstract] [Full Text] [Related]
9. Therapeutic response in oral dosage forms. Morrison AB Med Serv J Can; 1967 Mar; 23(3):349-59. PubMed ID: 6056377 [No Abstract] [Full Text] [Related]
10. GMPs vs GCPs: manufacturing and compounding definitions. Allen LV Int J Pharm Compd; 2013; 17(5):356. PubMed ID: 24459778 [No Abstract] [Full Text] [Related]
11. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related]
13. What is quality of medicines? Doogue MP; Thynne TR Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167 [No Abstract] [Full Text] [Related]
14. When pharmacies cause harm. Jha VM Chest; 2013 Aug; 144(2):717. PubMed ID: 23918132 [No Abstract] [Full Text] [Related]
15. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
16. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles]. Witschi T Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309 [No Abstract] [Full Text] [Related]
17. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction]. Hippenmeier F Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531 [No Abstract] [Full Text] [Related]
18. Problems Associated With Some Drug Formulations. Paul Y Indian Pediatr; 2019 Jun; 56(6):513-514. PubMed ID: 31278243 [No Abstract] [Full Text] [Related]